BlackRock Capital Allocation Term Trust of (BCAT) carries a Roarable Rating of D (Sell) with 44/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-03, BlackRock Capital Allocation Term Trust of (NYSE: BCAT) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 44/100 at a spot price of $13.63 (-1.16% 1D, market cap $1.49B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, BCAT ranks #821 in composite RQD confidence.
Within the Financials sector (Finance/Investors Services), BCAT carries a Roarable D (44/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, ECAT (BlackRock ESG Capital Allocation Term Trust of) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $1.46B) and KYN (Kayne Anderson Energy Infrastructure Fund Inc.) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $2.02B). Among the 5-stock peer group, BCAT leads on earnings multiple (N/A) while BCAT leads on capital efficiency (— ROIC).
For BlackRock Capital Allocation Term Trust of (BCAT), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity and sector rank #821 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
SEC XBRL Trailing 12 Months: 1% FCF Margin ($41.8M FCF) & 52% Gross Margin
Macro rate sensitivity & RSI-14 (52.3) create a -15 pt regime headwind
While BCAT currently carries a cautious 44/100 (D) rating due to Macro Regime Fit (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Financials with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($14.26) and Max Pain ($14.31) forces dealer call-delta covering toward $17.01.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
BlackRock Capital Allocation Term Trust of (BCAT) slipped -1.16% to $13.63, trading at 22% of its 52-week range ($12.91 – $16.2). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
Stock Traders Daily report covering BlackRock Capital Allocation Term Trust of (BCAT) market action, institutional positioning, and fundamental catalysts.
Weekly CEF update: sector performance, muni resilience, commodity weakness, HERZ tender results, and CLO equity selloff. Read the full analysis here.
NEW YORK, October 30, 2026--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced
Weekly CEF market update: sector winners and losers, DMA buyback news, ASGI rights offering, and key distribution changes.
NEW YORK, October 22, 2026--BlackRock Capital Allocation Term Trust (NYSE: BCAT) (the "Fund") today announced the successful completion of its transferable rights offer (the "Offer") which expired on October 21, 2026 (th
CEFs were mixed this week, with 10 of 26 sectors rising on price, 15 of 26 on NAV, and MLPs leading while Senior Loans lagging.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BCAT today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BCAT. Explore sector supply chains on /butterfly.
Across 1097 tracked Financials securities in the Roarable RQD universe, BlackRock Capital Allocation Term Trust of (BCAT) ranks #821 by composite RQD confidence (44/100, grade D) and #485 by equity capitalization ($1.49B). Within this direct 5-issuer industry benchmark cohort, BCAT leads on earnings valuation at N/A trailing P/E, while BCAT leads on capital efficiency and profitability with — ROIC and — gross margin. KYN currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with BCAT at 44/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BCAT
ACTIVE
BlackRock Capital Allocation Term Trust of | D | 44/100 | — | — | — | -1.16% | $1.49B | Benchmark Subject |
| ECAT BlackRock ESG Capital Allocation Term Trust of | D- | 41/100 | — | — | — | +0.45% | $1.46B | /ecat-vs-bcat → |
| KYN Kayne Anderson Energy Infrastructure Fund Inc. | D+ | 58/100 | — | — | — | -3.71% | $2.02B | /kyn-vs-bcat → |
| BTZ BlackRock Credit Allocation Income Trust | D- | 43/100 | — | — | — | -0.21% | $1.03B | /btz-vs-bcat → |
| BCX BlackRock Resources of | D | 45/100 | — | — | — | -1.17% | $1.01B | /bcx-vs-bcat → |
BlackRock Capital Allocation Term Trust of (BCAT) operates in Finance/Investors Services (Financials) with an equity capitalization of $1.49B, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
As of 2026-11-03, BlackRock Capital Allocation Term Trust of (NYSE: BCAT) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 44/100 at a spot price of $13.63 (-1.16% 1D, market cap $1.49B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, BCAT ranks #821 in composite RQD confidence.
Within the Financials sector (Finance/Investors Services), BCAT carries a Roarable D (44/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, ECAT (BlackRock ESG Capital Allocation Term Trust of) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $1.46B) and KYN (Kayne Anderson Energy Infrastructure Fund Inc.) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $2.02B). Among the 5-stock peer group, BCAT leads on earnings multiple (N/A) while BCAT leads on capital efficiency (— ROIC).
For BlackRock Capital Allocation Term Trust of (BCAT), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity and sector rank #821 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
BCAT last traded at $13.63 (-1.16% on volume of 490,733 shares), positioning the stock -4.42% below its 50-day simple moving average ($14.26) and -9.25% below its 200-day simple moving average ($15.02). Across its 52-week range of $12.91 to $16.20, BCAT sits at the 21.9% percentile with a 14-day RSI of 52.3 (NEUTRAL RANGE) and an implied next-earnings move of ±3.4% ($13.17 to $14.09).
BlackRock Capital Allocation Term Trust of (BCAT) earns a live Roarable RQD composite score of 44/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $13.63 (-1.16% 1D, market capitalization $1.49B).
BCAT is a NYSE-listed issuer classified under the Financials sector and the Finance/Investors Services industry. The profile identifies it as a publicly traded entity with a market capitalization of $1.5B. — describes its product offerings, customer base, or revenue model.
Upstream and downstream dependencies, sector correlations, and 2nd-order bottlenecks cannot be mapped from the supplied data. The only sector context available is the Financials / Finance/Investors Services classification and the beta of 1.0, which implies market-level sensitivity but does not identify specific ripple pathways.
Real-time company headlines, analyst actions, and sector developments for BlackRock Capital Allocation Term Trust of (BCAT) • Click "Debate This Headline" to argue it in the Roar Pit below
Stock Traders Daily report covering BlackRock Capital Allocation Term Trust of (BCAT) market action, institutional positioning, and fundamental catalysts.
Weekly CEF update: sector performance, muni resilience, commodity weakness, HERZ tender results, and CLO equity selloff. Read the full analysis here.
NEW YORK, October 30, 2026--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced
Weekly CEF market update: sector winners and losers, DMA buyback news, ASGI rights offering, and key distribution changes.
NEW YORK, October 22, 2026--BlackRock Capital Allocation Term Trust (NYSE: BCAT) (the "Fund") today announced the successful completion of its transferable rights offer (the "Offer") which expired on October 21, 2026 (th
CEFs were mixed this week, with 10 of 26 sectors rising on price, 15 of 26 on NAV, and MLPs leading while Senior Loans lagging.
Here is why I am bullish on BCAT here at $13.79: The forensic balance sheet pillar scores 13/20 with Piotroski F at 6/9, Altman Z at 2.5, and Debt/Equity at 0.5, the strongest support in the rating.. Compare BCAT's 0.0% operating margin and 0.0% ROIC against the rest of Finance/Investors Services. As long as cash conversion holds up, dips toward $13.10 are getting bought.
@BreakoutHunter Agree on the RQD 44/100 quality, though with 1.0 beta I'm scaling in with half-size at $13.79 and keeping dry powder in case we test $12.82.
Sitting on the sidelines or leaning short BCAT above $13.79. Valuation & margin reality check on BCAT at $13.79 before chasing here. Until Fundamental Cash Engine (11/20) and FCF yield (0.0%) inflect higher, upside is capped near $16.20.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Gideon Ashmere, Ellis Vennor, Tessa Rookmere, Soren Halewick, Iona Brackenford, Nadia Vellacrest, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your email address below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).